Theaflavin alleviates cisplatin-induced nephrotoxicity: Targeting SIRT1/p53/FOXO3a/Nrf2 signaling and the NF-kB inflammatory cascade
Food and Chemical Toxicology · 2025
DOI: 10.1016/j.fct.2025.115334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2025. Verfasst von Samyah T Alanazi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, 11433, Saudi Arabia. Hauptthemen laut MEDLINE: Cisplatin, Sirtuin 1, Forkhead Box Protein O3, Rats, Wistar. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Taif University.
Abstract (Originalsprache)
Cisplatin is a widely used chemotherapeutic agent. Nevertheless, a significant fraction of cisplatin-treated patients develops nephrotoxicity which limits cisplatin therapeutic implementation. The current work was devoted to investigate the potential nephroprotective impact of theaflavin against the cisplatin-induced nephrotoxicity using male Wistar rats as a mammalian model. The results indicated that theaflavin significantly improved the renal histopathological picture and glomerular filtration rate, along with reduced renal injury marker KIM-1, urinary albumin/creatinine ratio, serum creatinine, and urea. Mechanistically, theaflavin upregulated protein level of SIRT1 and downregulated the acetylated forms of the inflammatory transcription factor (TF) NF-kB, the antioxidant TF FOXO3a, and the pro-apoptotic TF p53 in the cisplatin-treated rats. Additionally, it upregulated the antioxidant TF Nrf2. In the same context, it suppressed the inflammatory responses, oxidative stress, and apoptosis. NF-kB nuclear translocation and levels of its responsive gene products IL-6 and TNF-α were suppressed. Lipids and DNA oxidation were reduced, and level of the antioxidant GSH and activity of the antioxidant enzymes SOD, GPx, and CAT were increased. The apoptotic markers caspase-3, BAX, and Bcl2 were modulated. Collectively, these findings highlight the nephroprotective competency of theaflavin against cisplatin-induced nephrotoxicity and underscore modulations of SIRT1, p53, FOXO3a, Nrf2, and NF-kB as potential targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, 11433, Saudi Arabia.
- Division of Biochemistry, Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia. Electronic address: s.salama@tu.edu.sa.
- Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia.
- Department of Public Health, College of Health Sciences, Saudi Electronic University, Riyadh, 13316, Saudi Arabia.
- Cardiac Center King Abdulaziz Medical City, Ministry of National Guard, Health Affairs, Riyadh, 11481, Saudi Arabia.
- Medical Imaging, King Abdulaziz Medical City, Ministry of National Guard, Health Affairs, Riyadh, 11481, Saudi Arabia.
Förderung
- Taif University
Zitieren
APA
Alanazi, S. T., Salama, S. A., Althobaiti, M. M., Bakhsh, A., Aljehani, N. M., Alanazi, E., Alanazi, M. T., & Musa, A. (2025). Theaflavin alleviates cisplatin-induced nephrotoxicity: Targeting SIRT1/p53/FOXO3a/Nrf2 signaling and the NF-kB inflammatory cascade. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2025.115334
Vancouver
Alanazi ST, Salama SA, Althobaiti MM, Bakhsh A, Aljehani NM, Alanazi E, et al. Theaflavin alleviates cisplatin-induced nephrotoxicity: Targeting SIRT1/p53/FOXO3a/Nrf2 signaling and the NF-kB inflammatory cascade. Food and Chemical Toxicology. 2025. doi:10.1016/j.fct.2025.115334
BibTeX
@article{Alanazi2025,
author = {Alanazi, Samyah T and Salama, Samir A and Althobaiti, Musaad M and Bakhsh, Afnan and Aljehani, Najla M and Alanazi, Ebtisam and Alanazi, Maha T and Musa, Arafa},
title = {Theaflavin alleviates cisplatin-induced nephrotoxicity: Targeting SIRT1/p53/FOXO3a/Nrf2 signaling and the NF-kB inflammatory cascade},
journal = {Food and Chemical Toxicology},
year = {2025},
doi = {10.1016/j.fct.2025.115334}
}
EUVIMED